Sharechat Logo

Tower underlying profit in line with year earlier

Wednesday 2nd February 2011

Text too small?

Underlying profit at insurer and investment company Tower for the three months to December tracked in line with the result from a year earlier, Tower chairman Tony Gibbs says.

Underlying profit excludes the effect of movements in the discount rate.

In the year to September 2010, Tower lifted net profit after tax 16% to $58.1 million. That included $6 million from movements in the discount rate following changes in investment markets. Underlying profit for the year was $52.1 million, 11% higher than a year earlier.

Speaking at Tower's annual meeting in Auckland today, Gibbs said the financial services and insurance sector in this country was subject to an unprecedented degree of regulatory change.

Tower was now working through the details of the prudential supervision of insurance businesses by the Reserve Bank and best practice anti-money laundering regulations.

Tower shares were up 2c in late morning trade to $1.97, having ranged between $1.75 and $2.09 in the past year.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

TruScreen Group Limited (NZX: TRU) Clinical Trial Results Highlight Efficacy of TRU Technology
20th October 2021 Morning Report
Freightways Limited (NZX: FRE) Acquisition of ProducePronto
19th October 2021 Morning Report
PGG Wrightson Limited (NZX: PGW) Guidance Update
Vital Limited (NZX: VTL) Provides Update on PSN LMR
18th October 2021 Morning Report
T&G Global Limited (NZX: TGG) FY21 Earnings Guidance Update
Arvida Group Limited (NZX: ARV) Successful Completion of $155m Placement
FreshLeaf: Cannabis on course to be 'medicine of the masses'